Home
Resources
Publications
Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors

Biomimetic Synthesis of Drug Metabolites in Batch and Continuous-Flow Reactors

Tamás Fődi, Gergő Ignácz, Balázs Decsi, Zoltán Béni, György I Túrós, József Kupai, Diána Balogh Weiser, István Greiner, Péter Huszthy, György T Balogh

Chemistry. 2018 Jul 2;24(37):9385-9392.

PMID: 29736963

Abstract:

A medium-throughput screening (MTS) of biomimetic drug metabolite synthesis is developed by using an iron porphyrin catalyst. The microplate method, in combination with HPLC-MS analysis, was shown to be a useful tool for process development and parameter optimization in the production of targeted metabolites and/or oxidation products of forty-three different drug substances. In the case of the biomimetic oxidation of amiodarone, the high quantity and purity of the isolated products enabled detailed HRMS and NMR spectroscopic studies. In addition to identification of known metabolites, several new oxidation products of the drug that was studied were characterized. Fast degradation and poor recovery of the catalyst under batch conditions was overcome by immobilization of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin iron(III) chloride (FeTSPP) on the surface of 3-aminopropyl-functionalized silica by electrostatic interaction. The supported catalyst was successfully applied in a packed-bed reactor under continuous-flow reaction conditions for the large-scale synthesis of amiodarone metabolites.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
LS761201	3-Aminopropyl functionalized silica			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: